Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone in Adults With Prader-Willi Syndrome
NCT03616509Phase 4Completed
- Sponsor
- Hospital Universitari Parc Taulí
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, double-blind, single-arm trial of genotropin miniquick in Prader-Willi syndrome (PWS), sponsored by Hospital Universitari Parc Taulí. Primary endpoint: Brain connectivity areas related with muscle tone maintenance at 24 months. Started Jun 2017; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03616509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616509.